The company’s lead investigational therapy, tanruprubart, demonstrated significant benefits over current standard care for Guillain-Barré ... This information is based on a press release ...

The oral presentation highlighted the benefits of tanruprubart in improving patient outcomes compared to current standard treatments for Guillain ... as a result of new information, future events ...

Discover the major causes of partial paralysis from stroke and trauma to inflammatory conditions and tumors, plus warning ...

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...

As per the order based on insights from the National Centre for Vector Borne Disease Control, dengue and chikungunya are now ...

A Brick Township native is sharing his story on how kindness saved his life while fighting a rare neurological disorder. Keith Rella was living a normal life as a husband and father when he suddenly ...

Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy that can lead to severe weakness of the limbs, face, and respiratory muscles. Its pathophysiology involves autoantibodies that ...

Background Guillain-Barre syndrome (GBS) is characterized by acute onset and progressive course, and is usually associated with a good prognosis. However, there are forms of poor prognosis ...

An oral presentation at ASCO & EHA Congress from the CARTITUDE-1 study highlighting heavily pre-treated patients that remain ...

Defense Secretary Pete Hegseth covered a fair amount of ground in his latest interview with his former Fox News colleague, Will Cain, and the beleaguered Pentagon chief acknowledged that he’s ...

"The extensive list provided by the DVLA encompasses a wide range of medical conditions that could impact driving ability.